Changes in HMO Concentrations throughout Lactation: Influencing Factors, Health Effects and Opportunities

• Main Authors: Caroline Thum, Clare Rosemary Wall, Gisela Adrienne Weiss, Wendan Wang, Ignatius Man-Yau Szeto, Li Day
• Format: Article
• Language: English
• Published: MDPI AG 2021-06-01
• Series: Nutrients
• Subjects: breast milk; maternal origin; secretor and Lewis blood type; gut microbiota; 2′-fucosyllactose; lacto-<i>N</i>-neotetraose
• Online Access: https://www.mdpi.com/2072-6643/13/7/2272

Human milk oligosaccharides (HMOs) are important functional biomolecules in human breast milk. Understanding the factors influencing differences in HMO composition and changes in their concentration over lactation can help to design feeding strategies that are well-adapted to infant’s needs. This review summarises the total and individual concentration of HMOs from data published from 1999 to 2019. Studies show that the HMO concentrations are highest in colostrum (average 9–22 g/L), followed by slightly lower concentrations in transitional milk (average 8–19 g/L), with a gradual decline in mature milk as lactation progresses, from 6–15 g/L in breast milk collected within one month of birth, to 4–6 g/L after 6 months. Significant differences in HMO composition have been described between countries. Different HMOs were shown to be predominant over the course of lactation, e.g., 3-fucosyllactose increased over lactation, whereas 2′-fucosyllactose decreased. Recent clinical studies on infant formula supplemented with 2′-fucosyllactose in combination with other oligosaccharides showed its limited beneficial effect on infant health.